US National Cancer Advisory Committee Meeting Notice
The National Cancer Institute (NCI) has announced a public meeting this month to review emerging data on immunotherapy combinations targeting PD-1/PD-L1 and CTLA-4 pathways, with preliminary results suggesting a 30% ... Read More